UA94245C2 - Anti-il-17 antibodies - Google Patents

Anti-il-17 antibodies

Info

Publication number
UA94245C2
UA94245C2 UAA200806723A UAA200806723A UA94245C2 UA 94245 C2 UA94245 C2 UA 94245C2 UA A200806723 A UAA200806723 A UA A200806723A UA A200806723 A UAA200806723 A UA A200806723A UA 94245 C2 UA94245 C2 UA 94245C2
Authority
UA
Ukraine
Prior art keywords
antibodies
human
immunoconjugates
humanized
chimeric
Prior art date
Application number
UAA200806723A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Барретт Аллан
Чи-кинь Чоу
Лиха Ханг
Лин Лю
Цзижон Лу
Кингман НГ
Джонатан Уэнделл Тетро
Эндрю Гордон Уэрнер
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of UA94245C2 publication Critical patent/UA94245C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen- binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
UAA200806723A 2005-12-13 2006-12-05 Anti-il-17 antibodies UA94245C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74995305P 2005-12-13 2005-12-13

Publications (1)

Publication Number Publication Date
UA94245C2 true UA94245C2 (en) 2011-04-26

Family

ID=47295229

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200806723A UA94245C2 (en) 2005-12-13 2006-12-05 Anti-il-17 antibodies

Country Status (2)

Country Link
NL (1) NL300829I2 (en)
UA (1) UA94245C2 (en)

Also Published As

Publication number Publication date
NL300829I2 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
EA200870050A1 (en) ANTI-IL-17-ANTIBODIES
HRP20181218T1 (en) Humanized anti-il-6 antibodies, compositions, methods and uses
IL244803A0 (en) Humanized anti-beta7 antibodies and uses therefore
ZA200707258B (en) Novel anti-PLGF antibody
TW200714290A (en) Anti-M-CSF antibody compositions having reduced levels of endotoxin
UA92504C2 (en) Anti-myostatin monoclonal antibody
MXPA06014510A (en) Compositions and methods for treating inflammatory disorders.
ATE545657T1 (en) TGF-BETA ANTIBODIES
MY149129A (en) Anti-sclerostin antibodies
EA200802168A1 (en) HUMANIZED ANTIBODY TO C-KIT
TW200639182A (en) Antibody variants and uses thereof
TW200745163A (en) Peptides that block the binding of IgG to FcRn
WO2009071696A3 (en) Humanized antibody molecules specific for il-31
MY156315A (en) Anti-vegf antibodies
WO2010017103A3 (en) Fully human anti-human nkg2d monoclonal antibodies
MY147468A (en) High affinity antibodies to human il-6 receptor
MX2010001975A (en) Humanized anti-cxcr5 antibodies, derivatives thereof and their uses.
TW200603828A (en) Treatment of disorders
MX2009003774A (en) Antibodies to lymphotoxin-alpha.
MX2023006777A (en) Compositions and methods comprising sfrp2 antagonists.
UA94245C2 (en) Anti-il-17 antibodies
UA98100C2 (en) Humanized monoclonal antibody that binds and neutralizes human nogo
UA96426C2 (en) Isolated human or humanized antibody that specifically binds to il-13